---
id: ITE-2024-048
type: ITE
year: 2024
number: 48
created: 2025-08-10 13:35:40.988251
tags:
- ITE
- question
- ITE-2024
- 2024-exam
answer: E
topic: Family Medicine
related_articles:
- title: PubMed Entry
  path: 2022/2022-09-ibrexafungerp-brexafemme-for-the-treatment-of-vulvovaginal-c.md
  similarity: 0.2
  link: '[[2022-09-ibrexafungerp-brexafemme-for-the-treatment-of-vulvovaginal-c|PubMed
    Entry]]'
- title: PubMed Entry
  path: 2022/2022-07-abametapir-074-xeglyze-for-the-treatment-of-head-lice.md
  similarity: 0.2
  link: '[[2022-07-abametapir-074-xeglyze-for-the-treatment-of-head-lice|PubMed Entry]]'
- title: PubMed Entry
  path: 2022/2022-12-another-study-fails-to-find-platelet-rich-plasma-injections.md
  similarity: 0.2
  link: '[[2022-12-another-study-fails-to-find-platelet-rich-plasma-injections|PubMed
    Entry]]'
- title: PubMed Entry
  path: 2022/2022-07-treatment-of-chagas-disease-in-breastfeeding-dyads.md
  similarity: 0.2
  link: '[[2022-07-treatment-of-chagas-disease-in-breastfeeding-dyads|PubMed Entry]]'
- title: PubMed Entry
  path: 2022/2022-08-cannabis-for-treatment-of-chronic-pain.md
  similarity: 0.2
  link: '[[2022-08-cannabis-for-treatment-of-chronic-pain|PubMed Entry]]'
topics:
- Family Medicine
related_articles_2023_2025:
- title: afp clinical answers
  path: 2023/12/2023-12-afp-clinical-answers.md
  similarity: 0.412
  link: '[[2023/12/2023-12-afp-clinical-answers|afp clinical answers]]'
- title: fatigue adults
  path: 2023/07/2023-07-fatigue-adults.md
  similarity: 0.41
  link: '[[2023/07/2023-07-fatigue-adults|fatigue adults]]'
- title: afp clinical answers
  path: 2024/08/2024-08-afp-clinical-answers.md
  similarity: 0.41
  link: '[[2024/08/2024-08-afp-clinical-answers|afp clinical answers]]'
- title: afp clinical answers
  path: 2024/10/2024-10-afp-clinical-answers.md
  similarity: 0.408
  link: '[[2024/10/2024-10-afp-clinical-answers|afp clinical answers]]'
- title: afp clinical answers
  path: 2023/07/2023-07-afp-clinical-answers.md
  similarity: 0.405
  link: '[[2023/07/2023-07-afp-clinical-answers|afp clinical answers]]'
last_updated: '2025-08-10T20:25:42.144372'
---

# Question ITE-2024-048

## Question
Of the following, which one is the most effective abortive treatment for cluster headache?

## Answer Choices
**A)** Hydromorphone ( Dilaudid)
**B)** Ketorolac
**C)** Ondansetron
**D)** Propranolol
**E)** Sumatriptan (Imitrex)

## Correct Answer
**E**

## Explanation
Cluster headache is a type of primary headache in the category of trigeminal autonomic cephalgia, and abortive therapy consists of 100% high -flow oxygen and triptans. Its typical onset is age 30 and it is 2 â€“3 times more common in males than females. The pain is severe and unilateral in the orbital, supraorbital, or temporal locations. It is associated with at least one of the following symptoms on the ipsilateral side: conjunctival injection or lacrimation, nasal congestion or rhinorrhea, miosis or ptosis, eyelid swelling, and sweating of the forehead and face. The pain can last from 30 minutes to almost 3 hours. Hydromorphone and ketorolac can be used to mask other types of pain but are ineffective in stopping cluster headache. Ondansetron stops vomiting, but its side effects include heada che. Propranolol can be used to prevent migraine.

## References
s Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition. Cephalalgia . 2018;38(1):1 -211. Malu OO, Bailey J, Hawks MK. Cluster headache: rapid evidence review. Am Fam Physician . 2022;105(1):24 -32. Manzoni GC, Taga A, Russo M, Torelli P. Age of onset of episodic and chronic cluster headache -a review of a large case series from a single headache centre. J Headache Pain. 2016;17:44. May A. Cluster headache: pathogenesis, diagnosis, and management. Lancet . 2005;366(9488):843 -855. Ray JC, Stark RJ, Hutton EJ. Cluster headache in adults. Aust Prescr . 2022;45(1):15 -20.

## Related AAFP Articles
- [[2022-09-ibrexafungerp-brexafemme-for-the-treatment-of-vulvovaginal-c|PubMed Entry]] (Relevance: 20%)
- [[2022-07-abametapir-074-xeglyze-for-the-treatment-of-head-lice|PubMed Entry]] (Relevance: 20%)
- [[2022-12-another-study-fails-to-find-platelet-rich-plasma-injections|PubMed Entry]] (Relevance: 20%)
- [[2022-07-treatment-of-chagas-disease-in-breastfeeding-dyads|PubMed Entry]] (Relevance: 20%)
- [[2022-08-cannabis-for-treatment-of-chronic-pain|PubMed Entry]] (Relevance: 20%)

---
*Source: 2024 ABFM In-Training Examination*